Carlsbad, CA, - October 30, 2006 - Micromet, Inc. (NASDAQ: MITI), a biopharmaceutical company focusing on the development of novel, proprietary antibody-based products for cancer, inflammatory and autoimmune diseases, will host a conference call and live webcast on Thursday, November 9, 2006, at 09:00am Eastern Time (03:00pm Central European Time) to discuss the company’s financial results for the third quarter ended September 30, 2006.
